CO4950613A1 - Derivados de benzoxazindiona y medicamentos que los contienen - Google Patents

Derivados de benzoxazindiona y medicamentos que los contienen

Info

Publication number
CO4950613A1
CO4950613A1 CO98011756A CO98011756A CO4950613A1 CO 4950613 A1 CO4950613 A1 CO 4950613A1 CO 98011756 A CO98011756 A CO 98011756A CO 98011756 A CO98011756 A CO 98011756A CO 4950613 A1 CO4950613 A1 CO 4950613A1
Authority
CO
Colombia
Prior art keywords
radical
alkyl
halogen
straight
branched chain
Prior art date
Application number
CO98011756A
Other languages
English (en)
Inventor
Heinisch Lothar
Steffen Wittmann
Mollmann Ute
Rolf Reissbrodt
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of CO4950613A1 publication Critical patent/CO4950613A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Derivados de benzoxazindiona de la Fórmula en la cual R1 representa H, COalquilo o COOalquilo, R2 representa H, alquilo, halógeno, y R3 está elegido entre los siguientes sustituyentes, en que: a) R3 representa Z-CHR4 -COR5 , siendo Z en donde R4 representa H, alquilo, fenilo o fenilo sustituido, con sustituyentes elegidos entre alquilo de cadena recta o ramificada, alcoxi de cadena recta o ramificada y alcoxicarbonato de cadena recta o ramificada, halógeno, hidroxilo, carboxilo y alquilo sustituido con halógeno, particularmente hidroxifenilo o aciloxifenilo, o R4 representa (CH2 )n COX, siendo X= OA, representando A un átomo de hidrógeno, alquilo, un ión de metal alcalino o un ión amonio o un ión amonio sustituido con alquilo y siendo X un radical de sustancia activa, particularmente un radical de un antibiótico ligado a través de un grupo OH o NH, y siendo n un número de 1 a 10, - 2 -o R4 representa (CH2 )n -Y, siendo Y un radical benzoxazindiona de la fórmula en donde R1 y R2 tienen los significados arriba definidos y ambos radicales benzoxazindiona pueden ser iguales o distintos entre sí, siendo n un número de 1 a 10, siendo R5 = OH, teniendo A el significado arriba definido, o siendo R5 un radical de una sustancia activa, particularmente un radical de un antibiótico ligado a través de un grupo OH o NH, o siendo R5 un radical NH-CHR8 -COR9 , en donde R8 representa H, alquilo, fenilo o fenilo sustituido, con sustituyentes elegidos entre alquilo de cadena recta o ramificada, alcoxi de cadena recta o ramificada, halógeno, hidroxilo, carboxilo y alquilo sustituido con halógeno, particularmente hidroxifenilo o aciloxifenilo, y siendo R9 igual OA, en donde A tiene el significado arriba definido, o representando R9 un radical de una sustancia activa, particularmente un radical de un antibiótico ligado a través de un grupo OH o NH, o representando R5 el radical en que X e Y tienen el significado arriba indicado y n es un número de 1 a 10 R6 representa H, alquilo o halógeno, R7 representa H, o acilo, y n es un número de 1 a 10 y m es un número de 1 a 2, o b) R3 representa el radical CHR4 -COR5 en donde R4 y R5 tienen los significados indicados, o c) R3 representa el radical = R18 en donde R10 y/o R11 representa H, alquilo, fenilo o fenilo sustituido, con sustituyentes elegidos entre alquilo de cadena recta o ramificada, alcoxi de cadena recta o ramificada y alcoxicarbonato de cadena recta o ramificada, halógeno, hidroxilo, carboxilo y alquilo sustituido con halógeno, particularmente hidroxifenilo o aciloxifenilo, siendo n un número de 1 a 10, pudiendo hallarse COR9 y R12 en cualquier posición y teniendo R9 el significado arriba definido y representando R12 un átomo de hidrógeno o un radical alquilo, halógeno, hidroxilo, alcoxi, el radical benzoxazindiona Y, o siendo R2 = = R19 en donde R1 y R2 tienen los significados arriba indicados, R14 y R15 tienen los significados de R1 y R2 , n es un número de 1 a 10, o - 3 -d) R3 representa = R20 en donde R13 y COR9 pueden hallarse en cualquier posición y R13 representa hidrógeno, alquilo, halógeno, hidroxilo, alcoxi o un radical benzoxazindiona Y, y R9 tiene el significado arriba definido, y p es un número de 0 a 2, o e) R3 = = R21 o R3 representa el radical = R22 en donde R9 tiene el significado arriba indicado, R16 representa H, alquilo, fenilo, o fenilo sustituido, con sustituyentes elegidos entre alquilo de cadena recta o ramificada, alcoxi de cadena recta o ramificada y alcoxicarbonato de cadena recta o ramificada, halógeno, hidroxilo, carboxilo y alquilo sustituido con halógeno, o f) R3 representa un radical de una sustancia activa, particularmente un radical de un antibiótico ligado a través de un grupo OH o NH,incluyendo ésteres de compuestos de la fórmula general I desdoblables bajo condiciones fisiológicas y que presentan un grupo carboxilo libre en el radical R3 .
CO98011756A 1997-03-05 1998-03-04 Derivados de benzoxazindiona y medicamentos que los contienen CO4950613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
CO4950613A1 true CO4950613A1 (es) 2000-09-01

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98011756A CO4950613A1 (es) 1997-03-05 1998-03-04 Derivados de benzoxazindiona y medicamentos que los contienen

Country Status (30)

Country Link
US (1) US6013647A (es)
EP (1) EP0863139B1 (es)
JP (1) JPH10316666A (es)
KR (1) KR19980079905A (es)
CN (1) CN1075064C (es)
AR (1) AR010125A1 (es)
AT (1) ATE200080T1 (es)
AU (1) AU737760B2 (es)
BR (1) BR9802894A (es)
CA (1) CA2230965A1 (es)
CO (1) CO4950613A1 (es)
CZ (1) CZ65098A3 (es)
DE (2) DE19708846A1 (es)
DK (1) DK0863139T3 (es)
ES (1) ES2157617T3 (es)
GR (1) GR3035834T3 (es)
HK (1) HK1015763A1 (es)
HU (1) HUP9800472A3 (es)
IL (1) IL123535A (es)
NO (1) NO310657B1 (es)
NZ (1) NZ329883A (es)
PE (1) PE71799A1 (es)
PL (1) PL325142A1 (es)
PT (1) PT863139E (es)
RU (1) RU2184114C2 (es)
SI (1) SI0863139T1 (es)
SK (1) SK28898A3 (es)
UA (1) UA45414C2 (es)
UY (1) UY24915A1 (es)
ZA (1) ZA981847B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
ATE441645T1 (de) 2005-05-25 2009-09-15 Actelion Pharmaceuticals Ltd Neue antibiotische derivate
TWI603962B (zh) * 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ATE200080T1 (de) 2001-04-15
IL123535A (en) 2000-10-31
UY24915A1 (es) 2000-12-29
DK0863139T3 (da) 2001-04-30
AU5645598A (en) 1998-09-10
HU9800472D0 (en) 1998-04-28
ES2157617T3 (es) 2001-08-16
DE19708846A1 (de) 1998-09-17
RU2184114C2 (ru) 2002-06-27
BR9802894A (pt) 2000-03-21
PE71799A1 (es) 1999-08-07
IL123535A0 (en) 1998-10-30
NO980929D0 (no) 1998-03-04
CN1195664A (zh) 1998-10-14
CA2230965A1 (en) 1998-09-05
JPH10316666A (ja) 1998-12-02
ZA981847B (en) 1998-09-08
AU737760B2 (en) 2001-08-30
CZ65098A3 (cs) 1998-09-16
PT863139E (pt) 2001-07-31
HUP9800472A2 (hu) 1999-06-28
HUP9800472A3 (en) 2000-09-28
KR19980079905A (ko) 1998-11-25
AR010125A1 (es) 2000-05-17
NO980929L (no) 1998-09-07
DE59800568D1 (de) 2001-05-03
SI0863139T1 (en) 2001-06-30
EP0863139A1 (de) 1998-09-09
GR3035834T3 (en) 2001-08-31
NZ329883A (en) 1999-04-29
UA45414C2 (uk) 2002-04-15
SK28898A3 (en) 1998-11-04
EP0863139B1 (de) 2001-03-28
NO310657B1 (no) 2001-08-06
US6013647A (en) 2000-01-11
HK1015763A1 (en) 1999-10-22
PL325142A1 (en) 1998-09-14
CN1075064C (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
SE8100304L (sv) Nya aminoxider med en perfluoralkylgrupp samt anvendning av dessa produkter i eldsleckningskompositioner
MX9605720A (es) Fotoiniciadores de borato a partir de monoboranos.
AR246516A1 (es) Compuestos derivados de quinazolina, composiciones que los contienen y metodos para aplicarlos y para prepararlos.
CO5160263A1 (es) Benzamidas sustituidas y medicamentos que las contienen
HUP0001322A2 (hu) Szulfinsavszármazékok, ezek előállítása és felhasználása
NO973550D0 (no) Hetero-aromatiske ring-substituerte fenyloksazolidinon-antimikrobielle midler
MY115188A (en) Flame retardant for styrene resin and resin composition comprising the same
GR900100459A (el) Ζιζανιοκτονες συνθεσεις με βαση ν-φωσφονομεθυλογλυκινη και η χρησιμοποιηση τους.
ES2035773B1 (es) Soluciones herbacidas a base de n-fosfonometilglicina.
CO4950613A1 (es) Derivados de benzoxazindiona y medicamentos que los contienen
ES2136691T3 (es) Poliuretanos ignifugos.
DE3875346T2 (de) Zusammensetzungen, die mit 1-oxo- oder thiokohlenwassserstoff substituierte azacycloalkane enthalten.
ES434726A1 (es) Procedimiento para la obtencion de compuestos hidroaromati- cos.
ES2061236T3 (es) Derivados de la urea, su preparacion y los medicamentos que les contienen.
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
CO4900028A1 (es) Derivados de catecol, su aplicacion terapeutica y medicamentos que lo contienen
KR870002325A (ko) 방염성 합성섬유
CZ119595A3 (en) Cyclohexane derivatives and their use
ATE241976T1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
ATE18044T1 (de) Substituierte thiazolidinylester von mineralsaeuren.
ES466826A1 (es) Procedimiento para la obtencion de derivados de acido benzo-hetero-cigliglioxilico.
AR248276A1 (es) Derivados de imidazolidina, procedimiento para producirlos y pesticidas que los contienen
KR900018033A (ko) 나프탈렌프로피온산 염
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
DE69303917T2 (de) Färbemittel für keratinische Fasern, die 4-Monoindolyl 1,2-naphthochinone enthalten, 4-Monoindolyl 1,2-naphthochinone